Sidibe v. Sutter Health

  1. November 07, 2024

    Sutter Health Could Face Retrial On Antitrust Claims In March

    Sutter Health is headed back to trial after the Ninth Circuit said "highly relevant" evidence was excluded from the 2022 trial where the hospital chain defeated claims that it had driven up the cost of insurance, and the court overseeing the matter says March is the earliest it can do.

  2. March 11, 2022

    Sutter Health Defeats $411M Antitrust Class Action At Trial

    A California federal jury cleared Sutter Health in a $411 million class action claiming the hospital giant used restrictive contracts with insurance companies to illegally boost prices and overcharge millions of premium-paying employers and individuals in Northern California, finding Friday that antitrust laws had not been violated.

  3. March 09, 2022

    Sutter Owes $411M In Antitrust Case, Jury Told At Trial's Close

    Sutter Health kept its prices high through anti-competitive means and should pay 3 million insurance buyers $411 million for overcharges, their lawyer argued Wednesday at the close of a California federal antitrust trial, calling the hospital chain's contracts with insurers restrictive, "unfair," "unjust" and "illegal."

  4. March 04, 2022

    Jury Told Kaiser, Not Sutter, Dominates Hospital Market

    A Columbia University economics professor testifying Friday as an expert for Sutter Health in a $411 million antitrust suit alleging the Northern California hospital giant overcharges for its services said the consumers' case defies "common sense" by ignoring the dominance of Kaiser Permanente in the market.

  5. March 03, 2022

    Sutter Antitrust Jury Hears ACA Spurred Lower-Priced Plans

    A California federal jury considering a $411 million antitrust case against Sutter Health heard videotaped testimony Thursday from a former Blue Shield executive who said that brokers began asking for lower-cost insurance options about the time the Affordable Care Act was introduced.

  6. February 25, 2022

    Sutter Exec Pressed On COVID Care In $411M Antitrust Trial

    A lawyer representing 3 million certified class members in a $411 million antitrust suit against Sutter Health over its allegedly onerous contracting provisions cross-examined one of its executives about its nursing staff shortages during the pandemic, saying his testimony on quality improvements had "opened the door" to the inquiry.

  7. February 23, 2022

    Sutter's Market Dominance Hiked Premiums $411M, Jury Told

    An economist testifying as an expert witness in a federal antitrust class action against Sutter Health said Wednesday that the hospital giant exploited its market power over California's top five health insurers, resulting in higher prices that cost millions of premium payers about $411 million.

  8. February 22, 2022

    Sutter Dominated Market; Employers Wanted It, Jurors Hear

    A Blue Shield executive testified Tuesday in a $411 million federal antitrust class action against Sutter that the hospital giant leveraged its dominant market position to force the insurer into costly contracts but also conceded that it worried about unhappy clients moving to other insurers if it dumped Sutter.

  9. February 18, 2022

    Sutter's Practices Raised Premiums For SF Workers, Jury Told

    The former director of San Francisco's health service system for municipal employees testified Friday in a $411 million federal antitrust class action against Sutter Health that the hospital giant's contracting practices blocked the city and county — the second-largest employer in Northern California — from offering workers lower premiums.

  10. February 17, 2022

    Ex-Sutter CFO Denies Flexing Market Muscle At Antitrust Trial

    Sutter Health's former chief financial officer rejected claims that the hospital giant built up its market power to stifle competition and charge higher prices, testifying Thursday in a $411 million antitrust class action that its goal is merely to have the money to fund necessary and state-mandated improvements.